Coronary angioplasty reduces the risk of spontaneous myocardial infarction in chronic stable patients.

Original title: Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Prevention of Spontaneous Myocardial Infarction in Subjects With Stable Ischemic Heart Disease. Reference: Sripal Bangalore et al. Circulation. 2013;127:769-781

In the context of coronary angioplasty complications may arise, such as a periprocedural infarction. However, this event does not have the same clinical consequences compared to a spontaneous infarction. 

The goal of this meta analysis was to evaluate the incidence of the different types of myocardial infarction in patients with stable ischemic heart disease treated with PCI vs. optimal medical therapy (OMT). 8070 patients with stable chronic angina were included from 12 randomized studies that compared PCI vs. OMT. The average follow up was 5 years (between 1.5 to 10.2 years) and only a small number of patients in the angioplasty group received drug eluting stents.

PCI was associated to a significant 24% incidence reduction of spontaneous acute myocardial infarction (RR=0.76; 95% IC, 0.58–0.99) (type 1 infarction of the universal definition). ON the other hand, PCI was associated with a greater incidence of periprocedural infarction (type 4 infarction). If we take into account all infarction events together, we won´t see any differences between both strategies. (RR=0.96; 95% CI, 0.74–1.21). PCI was also associated with a reduction in all cause mortality rate, though it did not reach a significant statistical value. (RR=0.88; 95% CI, 0.75–1.03).

Conclusion: 

PCI, compared to OMT, in patients with stable ischemic heart disease, was associated with a significant reduction of spontaneous MI risk (type 1 of the universal definition) and a tendency to lower mortality rate, although it did not reach a significant statistical value.

Editorial comment: 

A lot has been written about the important difference in prognosis of spontaneous MI vs. periprocedural MI. The whole work revolves around this detail, since the tally simply tracks the number of infarction events, but the risk these events involve is very different. This difference in terms of risk can be perceived in the tendency to a lower mortality in patients treated with PCI.

SOLACI.ORG

More articles by this author

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Left or Right Transradial Approach? Comparing Radiation Exposure in Coronary Procedures

Radiation exposure during percutaneous procedures is a problem both for patients and operators. The transradial is currently the preferred approach, vs. femoral; however, whether...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....